Improving and Optimizing your Viable Environmental Monitoring Program. Jason Willett Midwest Manager Veltek Associates, Inc.
|
|
- Evangeline Cox
- 6 years ago
- Views:
Transcription
1 Improving and Optimizing your Viable Environmental Monitoring Program Jason Willett Midwest Manager
2 Where did this Specification Come From? U.S. Railroad tracks are in width. That s a strange number Where did that specification come from? Because that was the specific width of the English railroad tracks and the U.S. Railroads were built by English settlers (expatriates). But, why is that so? Because, in England, the railroads were built by the same people who made the original tramcars. They had used the same gauges as the tramcars, which had that specific spacing. But, why is that so? Because, the people who built those tramcars used the same tools as they did for building wagons. And the wagon axles had that specific spacing. But, why is that so? Because, the the old, ragged, roads in England had wheel ruts on the sides of the road. This specific spacing was needed to keep the wagon wheels from maneuvering out of the ruts and breaking on the rough surfaces. But, why is that so? Because, the roads where originally built by Imperial Rome and those ruts were dug over many years by their chariots. That was the specific width of the chariot wheels. But, why is that so? The Roman chariots were specifically spaced just wide enough to accommodate the rear ends of two horses. 2
3 Where did this Specification Come From? So, the next time you are handed a specification and you are forced to wonder, What horse s ass came up with this?, you may be right! The response, We ve always done it this way, would be correct as well. 3
4 Let s Start From the Beginning
5 System Components Contamination Control is a proven system that prevents external contamination from entering controlled environments Environmental Monitoring tests that the system you designed is keeping your areas under control Cleaning and Disinfection corrects the inappropriate introduction of contamination 5
6 Areas of Control Within a Facility Personnel Equipment Disinfectants and cleaners Water HVAC Manufacturing Processes 6
7 What is Environmental Monitoring? It Is: Demonstrates Control of Aseptic Operations Identifies problems and trends in process and facilities Cleaning and Disinfection corrects the inappropriate introduction of contamination Data collection to support root cause analysis of excursions Is is Not: A test for final product release An analytical test Highly reproducible or recoverable Always constant Always linked to the smoking gun (cause and effect) Total picture of control 7
8 Global Regulations, Guidelines and Literature
9 Current Documentation United States United States Pharmacopeia 39, <1116> Microbiological Control and Monitoring of Aseptic Processing Environments FDA Guidance for Industry, Aseptic Processing, cgmp (October 2004) Europe GMP, Manufacture of Sterile Medicinal Products, Annex 1 (October 2009) World Health Organization Technical Report 961, Annex 6: GMPs for sterile pharmaceutical products (2011) Environmental Monitoring of Clean Rooms in Vaccine Manufacturing Facilities - Points to consider for manufacturers of human vaccines (November 2012) Japan Japanese Pharmacopoeia 16 (October 2011) - Microbiological Evaluation of Processing Areas for Sterile Pharmaceutical Products PDMA - Guidance on the Manufacture of Sterile Pharmaceutical Products by Aseptic Processing (October 2006) PIC/S Annex PE009-11: Guide GMP for Medicinal Products (March 2014) PDA Technical Report #13 (Revised) Fundamentals of an Environmental Monitoring Program (2014) 9
10 Determination of Sample Locations Document How to Determine Locations EU, WHO Based on formal risk analysis study and the results obtained during room classification and/or clean air devices PIC/S Based on a formal risk assessment. Consider data obtained during room classification and previous monitoring data Critical locations should be covered FDA Guidance Representative locations Locations posing the most microbiological risk to the product Locations where significant activity or product exposure occurs during production USP Locations considered should include those in proximity of the exposed product, containers, closures, and product contact surfaces Best selected with consideration of human activity during operations Evaluate impact of personnel movement and work within the area Entry points and areas within and around doors and airlocks The most likely route of contamination is airborne, so the samples most critical to risk assessment are those that relate to airborne contamination near exposed sterile materials. Japanese Guidance Japanese Pharmacopoeia Size of working area, scope of operations and process flow of materials and products Potential product contamination Not Specified 10
11 Viable Monitoring Frequency Document EU, WHO & PIC/S FDA Guidance USP Frequency The Grade A zone should be monitored at a frequency and sample size such that all interventions, transient events and any system deterioration would be captured and alarms triggered if alert limits are exceeded. Based upon the relationship to the operation performed Sample sizes should be sufficient to optimize detection of environmental contaminants at levels that might be expected in a given clean area Suggested Frequency of Sampling for Aseptic Processing Areas Sampling Area/Location Frequency of Sampling Clean Room/RABS Critical zone (ISO 5 or better) Active air sampling Each operational shift Surface monitoring At the end of the operation Aseptic area adjacent critical zone All sampling Each operating shift Other nonadjacent aseptic areas All sampling Once per day Isolators Critical zone (ISO 5 or better) Active air sampling Once per day Surface monitoring At the end of the operation Non-aseptic areas surrounding the isolator All sampling Once per Month 11
12 Viable Monitoring Frequency, continued Document Japanese Guidance Frequency To be determined in accordance to the air cleanliness level required for individual working areas. For example: Grade Microorganisms in Surfaces Particles air A & B Every working shift After completion of processing Continuously C & D Twice a week Twice a week Twice a week Japanese Pharmacopoeia Processing area Critical area (Grade A) Frequency of monitoring Each Shift Clean area adjacent to critical area (Grade B) Other clean areas (Grade C, D) Potential product/container contact areas Non-product/container contact areas Each Shift Twice a week Once a week 12
13 Viable Sampling Methods Document How to Determine Locations EU, WHO, PIC/S Air: Settle plates and volumetric air Surfaces: (Examples) swabs and contact plates FDA Guidance Air: Active device, optional settling plates Surfaces: Touch plates, swabs and contact plates USP Air: Choose from a variety of active samplers, settle plates Surface: contact plates or swabbing Japanese Guidance Air: Settle plates, impact and filtration methods Surfaces: contact plate or swabbing Japanese Pharmacopoeia Air: Settle plates, impact and filtration methods Surfaces: contact plates or swabs 13
14 Viable Limits EU, WHO, PIC/S & Japan Recommended Limits for Microbial Contamination* a Grade Air Sample - 90mm Settle Plates - CFU/m 3 CFU/4 Hours * b 55mm Contact Plates - CFU/Plate 5 Fingers Glove Print - CFU/Glove A <1 <1 <1 <1 B C D a. These are average values. b. Individual settle plates may be exposed for less than 4 hours. 14
15 Viable Limits FDA (2004 GMP) TABLE 1 - Air Classifications a Clean Area Classification (0.5 μm particles/ft 3 ) ISO Designation b > 0.5 μm particles/m 3 Microbiological Active Air Action Levels c (CFU/m 3 ) Microbiological Settling Plates Action Levels c,d (diam. 90mm; CFU/4 hours) ,520 1 e 1 e 1, , , , , ,520, a. All classifications based on data measured in the vicinity of exposed materials/articles during periods of activity. b. ISO designations provide uniform particle concentration values for cleanrooms in multiple industries. An ISO 5 particle concentration is equal to Class 100 and approximately equals EU Grade A. c. Values represent recommended levels of environmental quality. You may find it appropriate to establish alternate microbiological action levels due to the nature of the operation or method of analysis. d. The additional use of settling plates is optional. e. Samples from Class 100 (ISO 5) environments should normally yield no microbiological contaminants. 15
16 Viable Limits Japanese Pharmacopoeia Grade Table 4: Recommended limits for environmental microorganisms* 1 Airborne microorganisms* 2 (CFU/m 3 ) Minimum air sample (m 3 ) CFU on a surface Instruments/Facilities (CFU/24-30 cm 2 )* 3 Gloves A <1 0.5 <1 <1 B C D * 1 Maximum acceptable average numbers of microorganisms under each condition. * 2 These values are by using a slit sampler or equivalent. * 3 Viable microbe cell number per contact plate ( cm in diameter). When swabbing is used in sampling, the number of microorganisms is calculated per 25 cm 2. For gloves, usually, put their all fingers on the plate. 16
17 Viable Limits - United States Pharmacopoeia Microbial Control Parameters (Incident Rate): Suggested Initial Contamination Recovery Rates in Aseptic Environments* Room Classification Isolator/Closed RABS (ISO 5 or better) Active Air Sample (%) Settle Plate (9 cm) 4 h Exposure (%) Contact Plate or Swab (%) Glove or Garment (%) <0.1 <0.1 <0.1 <0.1 ISO 5 <1 <1 <1 <1 ISO 6 <3 <3 <3 <3 ISO 7 <5 <5 <5 <5 ISO 8 <10 <10 <10 <10 * All operators are aseptically gowned in these environments (with the exception of background environments for isolators). These recommendations do not apply to production areas for nonsterile products or other classified environments in which fully aseptic gowns are not donned. 17
18 Viable Monitoring of Compressed Gases Document EU, WHO & PIC/S How to Determine Locations Not Specified FDA Guidance USP Japanese Guidance Japanese Pharmacopoeia A compressed gas should be of appropriate purity (e.g., free from oil) and its microbiological and particle quality after filtration should be equal to or better than that of the air in the environment into which the gas is introduced. Microbial monitoring of manufacturing clean rooms, RABS, and isolators should include compressed gases, surfaces, room or enclosure air, and any other materials and equipment that might produce a risk of contamination. Environmental monitoring targets should also include compressed air or gas that comes in contact with the environment and equipment. Not Specified 18
19 ISO Regulations Misinterpretation? ISO Covers the classification of air cleanliness in cleanrooms and associated controlled environments exclusively in terms of concentration of airborne particles (has nothing to do with viable) ISO Establishes the principles and basic methodology of a formal system of biocontamination control (Formal System) for assessing and controlling biocontamination when cleanroom technology is applied for that purpose. Annex B: This annex describes a technique for determining the collection efficiency of samplers used for counting airborne microbes. Manufacturers or third-party testing organizations will usually perform this evaluation (this has no bearing on compressed gas/air). This is the unit s VALIDATION. ISO Specifies a test method for distinguishing viable, colony-forming, microbiological organisms from other solid particles which may be present in compressed air. A quantitative assessment MAY be made using the method given in Annex B (Slit to Agar) 19
20 Qualification of Viable Air Samplers An analysis provided by the manufacturer of the device (according to ISO 14698) An on-site comparative analysis (side by side) of the current device against the new device being implemented (e.g. Performance Qualification) Trending/performance of the newly implemented device (e.g. Performance Qualification) A study assuring that desiccation of the nutrient media does not occur during the length of the sample and subsequent incubation period. An Installation Qualification and Operational Qualification need to be completed prior to implementation. 20
21 Types of Viable Air Samplers
22 Portable Viable Air Samplers Sieve Impaction (many devices) Surface Air Sampler (SAS) Centrifugal Air Sampler (RCS) Slit to Agar Sampler (many devices) Sterilizable Microbial Atrium (SMA) Gelatin Filter Air Sampler (MD-80) What makes them all different? 22
23 Settle (Passive) Plates This method is still widely used as a simple and inexpensive way to qualitatively assess the environments over prolonged exposure times. Published data indicate that settling plates, when exposed for 4 5 hour periods, can provide a limit of detection for a suitable evaluation of the aseptic environment. Settling plates may be particularly useful in critical areas where active sampling could be intrusive and a hazard to the aseptic operation. One of the major drawbacks of most mechanical air samplers is the limited sample size of air being tested. 23
24 Isolator/RABS/Fixed Location Air Samplers Similar to their portable versions, however, these are designed so that the moving/active components (pumps, vacuums, electronics, etc.) are physically located outside of the barrier or room. It is generally NOT recommended to use a portable device inside an ISO 5 area for the following reasons: Portable devices are NOT able to be fully sterilized Portable devices generate particles Portable devices disrupt unidirectional airflow 24
25 Viable Compressed Gas Samplers 25
26 Rapid Technologies for Viable Air Sampling 26
27 Examples of Installed HMI/TouchScreens 27
28 Examples of Fixed Sample Locations 28
29 Ability to Monitor/Control from Outside ISO 5 29
30 Document Microorganism Incubation Conditions EU, WHO, PIC/S Not Described Not Described FDA Guidance USP Japanese Guidance Japanese Pharmacopoeia Media Selection & Incubation Fungi (yeast & molds) as well as bacteria Bacteria, yeast, and molds. Strict anaerobes not performed, but micro-aerophilic organisms may be sampled for, if warranted. Aerobic Bacteria, fungi (yeast & molds) & anaerobic bacteria Aerobes, Yeast, fungi & Anaerobes (not typically targeted) TABC: C for Hours TCYM: C for 5 7 Days Time and incubation are set once appropriate media is determined. SCDM (TSA): C for not less than 72 hours (longer for slow growers) The incubation condition of the medium should be suitable for growth of the target microorganisms (Huh?) Aerobes: C for more than 5 days Fungi: C for more than 5 days Anaerobes: C for more than 5 days If SCDM is used for TVC, then C for more than 5 days First incubate at C temperature for 72 hours for fungal growth and then same plates transferred to C for further 48 hours for bacterial growth. Favors Yeast & Molds First incubate at C temperature for 48 hours for bacterial growth and then same plates transferred to C for further 72 hours for fungal growth. Favors Gram Positive Cocci 30
31 Let s Apply What We Now Know You currently manufacture a single batch, spanning an 8 hour operating shift Air Sampler A - operates at 180 L/Min and samples a cubic meter in 5.5 minutes. Air Sampler B - operates at 100 L/Min and can utilize an interval sampling mode. Air Sampler C - operates at 28.3 L/Min and can actively sample for 3-4 hours on a single plate. How many plates do you need to sufficiently cover your production, how many will you bring into the APA at a time? How many interventions have you planned for plate changes (do you stop)? How many plates will you utilize (and subsequently have to review)? What did you potentially miss between samples/sampling? 31
32 What We May Have Missed Multiple air samples can lead to false positives (operator/analyst contamination), mishandled plates & more laboratory work. Non-sampling time between plate changes (or during passive state of of interval sampling) can result in missed contamination events. 32
33 Establishing and Executing Alert & Action Levels
34 Establishing Alert & Action Levels Document EU, WHO & PIC/S How to Determine Locations Appropriate alert and action limits should be set for the results of particulate and microbiological monitoring. If these limits are exceeded operating procedures should prescribe corrective action. FDA Guidance Based on : The relationship of the sampled location to the operation The need to maintain adequate microbiological control throughout the entire sterile manufacturing facility Historical databases, media fills, cleanroom qualification and sanitization studies USP Alert Levels: Not Specified Action levels: Should be based on empirical process capability Japanese Guidance Action level by referring to data contained in monitoring frequency table. Alert level based on results of a PQ test Japanese Pharmacopoeia An environmental control program document is prepared for each area used for the processing of sterile pharmaceutical products. The procedures in the document include: 5) alert and action levels, and 6) actions to be taken when specified levels are exceeded. 34
35 Establishing Alert & Action Levels Number Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec G+C G+R G-R YST Mold 35
36 Executing Alert & Action Levels Regulations require: Immediate follow-up Identification of microorganisms Corrective actions/preventive actions (CAPAS) if appropriate Indicates potential deviation from normal operational conditions Document and follow-up Additional or modified sample plan Designed to allow appropriate capability of reaction before reaching Action level No actions required 36
37 Identification of Microorganisms
38 Identification of Microorganisms Document Microorganism EU, WHO, PIC/S, Japanese GMP & Japanese Pharmacopoeia Not Described FDA Guidance Monitoring of critical and immediately surrounding clean areas as well as personnel should include routine identification of microorganisms to the species (or, where appropriate, genus) level Establishing an adequate program for differentiating microorganisms in the lesser-controlled environments, such as Class 100,000 (ISO 8), can often be instrumental in detecting such trends (migration of microorganisms into clean areas) At minimum, the program should require species (or, where appropriate, genus) identification of microorganisms in these ancillary environments at frequent intervals to establish a valid, current database of contaminants present in the facility during processing (and to demonstrate that cleaning and sanitization procedures continue to be effective) USP A successful environmental control program includes an appropriate level of identification of the flora obtained by sampling. A knowledge of the flora in controlled environments aids in determining the usual microbial flora anticipated for the facility and in evaluating the effectiveness of the cleaning and sanitization procedures, methods, agents and recovery methods. The information gathered by an identification program can be useful in the investigation of the source of contamination, especially when recommended detection frequencies are exceeded. 38
39 Identification of Microorganisms Corynebacterium tuberculostearicum 2.9% Bacillus cereus, 4.3% Staphylococcus hominis, 5.6% Staphylococcus epidermidis, 8.7% Staphylococcus luteus, 9.6% Staphylococcus capitis, 2.8% Bacillus pumilus, 2.7% Staphylococcus warneri, 2.5% Bacillus subtilis, 2.4% Bacillus licheniformis, 0.9% Staphylococcus haemolyticus, 2.2% Ralstonia pikettii, 1.7% Paenubacillus glucanolyticus, 1.5% Bacillus megaterium, 1.5% Proprionibacterium acnes, 1.0% Source: Bacteria Most Often Submitted for Identification Testing During 2010, Barry A. Friedman, posted May 17,
40 Distribution of Microorganisms People Air/Soil Water/Liquid 40
41 Identification of Microorganisms Biochemical (Selective Assays) Gram Stain Catalase Test Coagulase Test Oxidase Test Indole Test 41
42 Identification of Microorganisms Phenotypic Identification (incorporates reactions to different chemicals or different biochemical markers) BD BBL Enterotube II BD BBL Crystal ID Panels 42 BioMerieux API Strips 42
43 Identification of Microorganisms Phenotypic Identification - continued Biolog GEN III OmniLog ID System BioMerieux Vitek 2 System 43
44 Identification of Microorganisms Genotypic Identification (based on gene sequencing, 16S rrna gene) Thermo Fisher Scientific MicroSeq DuPont RiboPrinter 44
45 Identification of Microorganisms Proteotypic (MALDI-TOF): Spectral analysis based on ribosomal protein expression BioMerieux Vitek MS System Bruker MALDI Biotyper 45
46 Identification of Microorganisms Fatty Acid Analysis/GC Optical/Raman Spectroscopy Midi Sherlock Q-FAME Batelle REBS 46
47 Viable Monitoring of Surfaces
48 Different Surface Types Irregular Surfaces Residues Particulate and Viable particulates All may complicate monitoring and disinfection 48
49 Sampling Methods Contact plates (RODAC) and swabs Contact Plate and Swab recovery studies Contact plates can offer better recovery than swabs and utilized more often (where surface and location permits) Flocked swabs offer better recovery than spun/cotton swabs due to physical composition Rinse samples can be performed on interior surfaces of kettles and tanks using membrane filtration and sterile water (or Ringer s, etc). Sampling done on equipment, work surfaces, floors, walls and product contact surfaces after production is complete 49
50 Viable Monitoring of Personnel
51 Viable Monitoring of Personnel Personnel Monitoring: Routine during production Gloved fingers: underside where contaminants are most likely Critical gown sites for aseptic operations Contact plate testing of people leaving/exiting area Routine failures on a person requires a corrective action (re-training and/or re-qualification) Gown Training Certification Surface sampling of gown at key garment locations Personnel MUST participate in a media challenge at least once annually if they will be filling aseptic product 51
52 Gowning Qualification Set strict limits for qualification Remove those who fail and retrain them Testing needs to be done by Quality. They should not qualify themselves Determine Qualification Test locations (8) Hood, goggles, mask, zipper, sleeves, hands (both), thighs Re-qualify on an annual basis 52
53 Viable Monitoring of Water Systems
54 Water Sampler Collection & Hold Time Sample Collection and Testing After validation of controlled state Collect samples consistent with manufacturing practices Sample locations Test as soon as possible after collection Samples should be taken from holding and distribution system to assess microbiological quality for its intended use If manufacturing flushes use points prior to use, collect samples using same flush cycle Sample through hoses (not directly from the tap) if manufacturing requires use of hoses Chosen to demonstrate microbiological quality throughout the distribution system If not possible, refrigerate samples at 2-8 C upon receipt in the laboratory Time between collection and examination 24 hours. 54
55 Microbial Monitoring/Testing of Water Azbil BioVigilant IMD-W Manual Filtration EMD Millipore Milliflex Mettler-Toledo 7000RMS EMD Millipore Milliflex Quantum BioMerieux ScanRDI 55
56 Cleaning & Disinfection
57 Chemical Selection Sanitizers Reduce some level of microbial contamination; least effective agents Examples: Isopropyl alcohol (70% IPA), and Ethyl alcohol (62% EtOH) Disinfectants Reduce higher levels of vegetative microorganisms than sanitizers depending on the strength and contact time Examples: Quaternary Ammonium compounds, Phenolics Sporicides Effective against all microorganisms provided the wetted contact time is achieved Examples: Sodium hypochlorite, Hydrogen peroxide/peracetic acid, Hydrogen peroxide (6% or greater) 57
58 Cleaning & Disinfection Program Cleaning and Disinfection address mistakes in the Contamination Control System If done appropriately, it cleans particulates and microbes that have been allowed to enter the controlled area It does not have any preventive capabilities. It cleans or kills what exists but does not prevent the introduction of particulates and microbes, nor their growth. Too many times disinfection is considered a preventive measure. It is not. 58
59 Cleaning versus Disinfection Proper cleaning is critical for effective disinfection Would you disinfect without brushing or cleaning the surface? 59
60 The System is a Cycle 4. Assure appropriate application and test again 1. Control What Enters the Environment 3. Validate disinfectants and disinfection system in conjunction with cleaning and disinfection SOP s 2. Test the environment and address the contamination 60
61 In Conclusion Understand Environmental Monitoring because it can be a very unique and daunting task The guidelines are just that, guidelines. Establish a well-justified and validated program that works for you and meets the various global recommendations A good EM program also controls the introduction of contamination Cleaning and disinfection are critical aspects to contamination control Monitoring systems should not affect final product 61
62 Any Questions? 62
Environmental Monitoring of Aseptic Processing Areas - 2
Environmental Monitoring of Aseptic Processing Areas - 2 A war against an invisible enemy DCVMN - Víctor Maqueda - May 30, 31, June 1 2016 1 Active Air Monitoring (Viables) Air Sieve Samplers Draw air
More informationHow to Handle Excursions in Environmental Monitoring (EM) and Personnel Monitoring (PM) in an Aseptic Processing Plant
How to Handle Excursions in Environmental Monitoring (EM) and Personnel Monitoring (PM) in an Aseptic Processing Plant Randy Hutt, Ph.D. Associate Director Sterility Assurance and Microbiology Luitpold
More informationEnvironmental Monitoring of Aseptic Processing Areas - 1
Environmental Monitoring of Aseptic Processing Areas - 1 A war against an invisible enemy DCVMN - Víctor Maqueda - May 30, 31, June 1 2016 1 Training Course Agenda Overview of Environmental Monitoring
More informationA risk based approach to managing environmental excursions
A risk based approach to managing environmental excursions RACI: Monitoring & protecting your GMP facility s Environment 20 th April Ngoc Anh-Thu Phan www.eurofins.com Content Introduction Risk Assessment
More informationUNDER SECRETARY FOR HEALTH S INFORMATION LETTER MICROBIOLOGICAL ASSESSMENT OF PHARMACEUTICAL CLEANROOMS
DEPARTMENT OF VETERANS AFFAIRS Veterans Health Administration Washington DC 20420 IL 10-2006-008 In Reply Refer To: 10NB UNDER SECRETARY FOR HEALTH S INFORMATION LETTER MICROBIOLOGICAL ASSESSMENT OF PHARMACEUTICAL
More informationFDA s Guidance for Industry
Sterile Drug Products Produced by Aseptic Processing - CGMPs Midwest FDC Conference November 4 2005 Susan Bruederle, Investigator FDA / ORA / Central Region Chicago District / Hinsdale IL FDA s Guidance
More informationThis compilation of the complex
Manufacturing in a Global Marketplace Reference Matrices on Regulations for Classified (Environmentally Controlled) Areas Betty Seawell, William Miele, and Jean Huxsoll The complex world of international
More informationBIO & PHARMA ANALYTICAL TECHNIQUES
BIO & PHARMA ANALYTICAL TECHNIQUES Chapter 11 by Dr. Siti Umairah Mokhtar Faculty of Engineering Technology umairah@ump.edu.my Chapter Description Aims Discuss theory, principles and application of analytical
More informationCONTENTS About the Authors xiii 1 ENVIRONMENTAL MONITORING 1 Jeanne Moldenhauer Overview 1 Components of an Environmental Control System 2 Facility Design and Maintenance 3 Documentation Systems and Procedural
More informationBiocontamination control in pharmaceutical production
White Paper Data Sheet Biocontamination control in pharmaceutical production and compliance to ISO 14698 with validated active microbial air samplers Tim Sandle, Ph.D., Head of Microbiology at Bio Products
More informationTECHNICAL LEAFLET. MEDI-MEDIA-FILL KIT SUPPLY PACKAGE (Code: MR-25/S)
TECHNICAL LEAFLET MEDI-MEDIA-FILL KIT SUPPLY PACKAGE (Code: MR-25/S) TEST AGAR PLATES FOR PERSONNEL AND ENVIRONMENTAL MICROBIOLOGICAL MONITORING COMPONENTS: Test Agar Plates Data Log Sheet Technical Leaflet
More informationEnvironmental Control Requirements. Gordon Farquharson July 2017
Environmental Control Requirements Gordon Farquharson July 2017 Learning Objectives Learn how contamination control standards and guidance sets requirements for Critical Parameters ISO-14644-1 Classification
More informationOverview of a sterility assurance program for PET drugs
Coalition for PET Drug Approval Radiopharmaceutical Sciences Council Overview of a sterility assurance program for PET drugs Eric Webster, PETNET Solutions Disclosures Employee of PETNET Solutions, a Siemens
More informationWebinar. The New EU-GMP Annex 1 draft Dupont. GOP-Innovations your Partner for Practical Training and e-learning. 8 June 2018
Webinar The New EU-GMP Annex 1 draft Dupont 8 June 2018 GOP-Innovations your Partner for Practical Training and e-learning Milenko Pavičić Pharmaceutical microbiologist, consultant, trainer, coach 10 years
More informationUSP <1116> and Contamination
USP and Contamination Recovery Rates Scott Sutton ABSTRACT United States Pharmacopeia (USP) "Microbiological Control and Monitoring of Aseptic Processing Environments" approaches analysis
More informationPost Sterilization Lab Contamination
Post Sterilization Lab Contamination PDA Midwest May 2018 Bob Stringham Microbiology Manager Overview > Ethylene Oxide sterilization utilizes Process Challenge Device (PCD) to support lot release > PCDs
More informationEU GMP ANNEX 1 CHANGES CLARIFICATION AND IMPACT
1 EU GMP ANNEX 1 CHANGES CLARIFICATION AND IMPACT UNDERSTAND THE PROGRESSION OF REGULATORY THINKING AND HOW TO SUCCESSFULLY IMPLEMENT THE PROPOSED CHANGES BALTIMORE, MD MAY 6TH AND 7TH, 2019 UNIVERSITY
More informationApproval Block. Prepared by: Signature Date. Evan Parnell 18 JUN Reviewed by: Signature Date. Brian Flynn 18 JUN 2014
ATS-SOI-5805 Page: 1 of 5 Approval Block Prepared by: Signature Date Evan Parnell 18 JUN 2014 Reviewed by: Signature Date Brian Flynn 18 JUN 2014 Approved by: Signature Date Kristal Jewell 18 JUN 2014
More informationIN THIS SECTION MICROBIOLOGY TESTING EXPERT SOLUTIONS FOR PRODUCT DEVELOPMENT. Bacterial Endotoxin (LAL) Testing
EXPERT SOLUTIONS FOR PRODUCT DEVELOPMENT IN THIS SECTION MICROBIOLOGY TESTING Microbial assays involve a variety of tests, from the determination of the numbers and types of organisms naturally present
More informationLUNCH AND LEARN. September 11, CE Activity Information & Accreditation
LUNCH AND LEARN Environmental Monitoring and Contamination Control September 11, 2015 Featured Speaker: Scott Sutton, Ph.D. The Microbiology Network N. Chili, New York 1 CE Activity Information & Accreditation
More informationManaging Your Environmental Isolates
Managing Your Environmental Isolates The Controversy Good practice includes the periodic challenge of prepared media with low levels of organisms. This includes USP indicator organisms as well as normal
More informationPhEn-602 Notes # 4 J. Manfredi
PhEn-602 Notes # 4 J. Manfredi Spring 2009 1 Basic definitions Clean Room: A room in which the concentration of airborne particles is controlled and contains one or more clean zones Clean Zone: A defined
More informationTests to Support Sterility Claim. Imtiaz Ahmed
Tests to Support Sterility Claim Imtiaz Ahmed Sterile Product As per TGO 77, a sterile product must comply with the requirements of the following tests: Sterility Test Bacterial Endotoxins Test Appendix
More informationComplaints Investigations Root Cause Analysis
Complaints Investigations Root Cause Analysis Dr. Ademola Daramola International Relations Specialist Drugs US FDA India Office New Delhi February 22nd 2018 Information presented in this presentation does
More informationMicrobiological Consideration for Non-Sterile Pharmaceutical
May 1-3, 2012 Javits Center New York, NY Microbiological Consideration for Non-Sterile Pharmaceutical Dr. Leonard W. Mestrandrea Principal Consultant MESTRANDREA CONSULTING LLC Title Date Microbial Control
More informationThe Parenteral Drug Association
C O N F E R E N C E R E P O R T Equipment Cleaning Microbial Control Issues By Destin A. LeBlanc, M.A. Cleaning Validation Technologies Validation: The Parenteral Drug Association (PDA) spring conference
More informationGeneral European OMCL Network (GEON) QUALITY MANAGEMENT DOCUMENT
General European OMCL Network (GEON) QUALITY MANAGEMENT DOCUMENT PA/PH/OMCL (16) 86 R2 MANAGEMENT OF ENVIRONMENTAL CONDITIONS Full document title and reference Document type Management of Environmental
More informationOn behalf of the PHSS Pharmaceutical and Healthcare Sciences Society (UK).
31 st March 2015 Submission of comments on ' Concept paper on the revision of annex 1 of the guidelines on good manufacturing practice manufacture of sterile medicinal products EMA/INS/GMP/735037/2014
More informationMicrobiological Cleaning Method Validation
Microbiological Cleaning Method Validation The purpose of cleaning procedures should never be to reduce bioburden to an acceptable level! Fergus O Connell QA Manager Eurofins ams Laboratories www.eurofins.com
More informationPDA: A Global. Association. Contamination Control: Particles, Bio-contamination, Aseptic manufacturing. PDA Parenteral 2014 Munich Conference
PDA Parenteral 2014 Munich Conference PDA: A Global Contamination Control: Particles, Bio-contamination, Bioburden Association and Endotoxins in Aseptic manufacturing. James Drinkwater F Ziel Head of Aseptic
More informationAvoid recurrent microbial contamination using trending of historical data. El Azab Walid Technical Service Manager STERIS
Avoid recurrent microbial contamination using trending of historical data El Azab Walid Technical Service Manager STERIS Agenda Factors influencing the cleaning and disinfection performance Recurring microbial
More informationJulie Roberts. Audit hot Topics and Regulatory Requirements
Julie Roberts Audit hot Topics and Regulatory Requirements Overview Hot Topics Examples in warning letters Tips to detecting data integrity Recent changes in regulatory requirements Hot Topics Microbial
More informationOverview and Introduction Annex 1 Revision
Overview and Introduction Annex 1 Revision Paul Moody, Inspector Pharmig Current Hot Topics in Pharmaceutical Microbiology, Dublin May 30 th, 2018 Scope History Process of Revision Rationale for Revision
More informationNHS QA Symposium, September 2013
1 www.pmtgb.com Germany - Benelux T o g e t h e r W e c r e a t e S o l u t i o n s France - Great Britain NHS QA Symposium, September 2013 John Cobb Microbiology Support Manager 2 www.pmtgb.com Germany
More informationImplementation of Enhanced Active Air Particle Counting. Jeffrey W. Weber Kalamazoo, MI May 5, 2015 PDA Midwest
Implementation of Enhanced Active Air Particle Counting Jeffrey W. Weber Kalamazoo, MI May 5, 2015 PDA Midwest Agenda Introduction Regulatory Aspects Case Study: Investigation Future Role: Elimination
More informationASEPTIC BIOPHARMACEUTICAL MANUFACTURING: FAQs
ASEPTIC BIOPHARMACEUTICAL MANUFACTURING: FAQs THE BIOTRAK REAL-TIME VIABLE PARTICLE COUNTER UNDERSTANDING, ACCELERATED REDUCE RISK INCREASE EFFICIENCY IMPROVE PROCESS UNDERSTANDING The BioTrak Real-Time
More informationUSP Chapter 823 USP 32 (old) vs. USP 35 (new)
USP Chapter 823 USP 32 (old) vs. USP 35 (new) Sally W. Schwarz, MS, BCNP Research Associate Professor of Radiology Washington University School of Medicine St. Louis, MO Why USP Chapter ? FDA has
More informationBioburden Contamination Control: A Holistic Overview
Bioburden Contamination Control: A Holistic Overview Scott Sutton, PhD Microbiology Network, Inc. Scott Sutton, PhD is the Principal of Microbiology Network, Inc (http:// microbiologynetwork.com/) a company
More informationDisinfection Qualification Testing
Disinfection Qualification Testing Considerations for Aseptic & Cleanroom Manufacturing Environments White Paper Considerations for Aseptic and Cleanroom Manufacturing Environments Obtaining the highest
More informationIs it true, Annex 1 revision will have no impact on resources or cost? Walid El Azab Technical Service Manager STERIS
Is it true, Annex 1 revision will have no impact on resources or cost? Walid El Azab Technical Service Manager STERIS Agenda Annex 1 revision why? Impact of the change on the field Conclusion The Revision
More informationPreparing Your Aseptic Processing Facility for an FDA Inspection. Valerie Welter, Director Quality Bayer HealthCare March 10, 2014
Preparing Your Aseptic Processing Facility for an FDA Inspection Valerie Welter, Director Quality Bayer HealthCare March 10, 2014 Agenda Regulatory Requirements Establishing your Approach Aseptic Controls
More informationHVAC and Risk Management RACI Meeting 7 th December Agenda. Design. Project Management. Context. Qualification. Construction
HVAC and Risk Management RACI Meeting 7 th December 2011 Dr Stephen Firmer Asia Pacific Consultants Pty Ltd Agenda Context Project Management Design Construction Qualification Routine Control /Potential
More informationANNEX 1: COMMENT SUBMISSION DOCUMENT
Submission Comments on: GMP Annex 1: Proposal for amendments to the environmental classification table for particles and associated text, amendment to section 42 concerning acceptance criteria for media
More information70% Isopropyl Alcohol
by A Study Monitoring 7% Isopropyl Alcohol Sterility in Use Prepared by: Lara Soltis, Wendy Hollands and Allen Spivey VOLUME XV NO. 1 3.18 REFORMATTED FROM 4.6 A Study Monitoring 7% Isopropyl Alcohol Sterility
More informationAnnex A2. Guidance on Process Validation Scheme for Aseptically Processed Products
Annex A2 Guidance on Process Validation Scheme for Aseptically Processed Products 1 Table of content 1 PURPOSE... 3 2 SCOPE... 3 3 GENERAL INFORMATION... 3 4 INFORMATION NEEDED FOR ASEPTIC PROCESSES VALIDATION...
More informationAseptic Process Validation
Aseptic Process Validation IMB GMP Information Seminar 27 th September 2012 Gerard Sheridan, Inspector Date Insert on Master Slide Slide 1 Overview Guidance Best Practices Common Deficiencies Slide 2 Aseptic
More informationINSPECTOR S OBSERVATIONS AND WARNING LETTER
Microrite, Inc. San Jose, CA, USA, http://www.microrite.com AIR VELOCITY MEASUREMENTS AND CORRELATION TO SMOKE STUDIES FOR ASEPTIC OPERATIONS KEYWORDS Air Velocity, Air Flows, Smoke Study, Air Pattern
More informationRecent USP Updates May, 2013
Recent USP Updates May, 2013 Don Singer GSK Bioburden Control of Non-sterile Drug Substances and Products The chapter emphasizes control as a risk mitigation strategy The chapter recommends a risk-based
More informationGuidance for Industry
Guidance for Industry for the Submission Documentation for Sterilization Process Validation in Applications for Human and Veterinary Drug Products Center for Drug Evaluation and Research (CDER) Center
More informationContamination Risk Assessment in Aseptic, Non-Sterile and Terminally Sterilized Products March 7 th & 8 th Raleigh, NC
Contamination Risk Assessment in Aseptic, Non-Sterile and Terminally Sterilized Products March 7 th & 8 th Raleigh, NC Contamination risk levels differ in aseptic, and non-sterile and terminally sterilized
More informationBest Practice in Environmental Monitoring
Best Practice in Environmental Monitoring Annette Grundy July 12 2016 1 Acknowledgement Dr Ed Tidswell previous roles at Baxter Senior Director R&D and Quality Director USP expert committee member Ed was
More informationPROCESS VALIDATION ROCHAPON WACHAROTAYANKUN, PH.D.
Basic GMP Requirement PROCESS VALIDATION ROCHAPON WACHAROTAYANKUN, PH.D. Topic Process validation What and Why? Principle of process validation Manufacturing process validation Aseptic process validation
More informationWhy Do I Test, What Do I Test & When Do I Test It? Ross Caputo, PhD Chief Technical Officer Eagle Analytical Services
Why Do I Test, What Do I Test & When Do I Test It? Ross Caputo, PhD Chief Technical Officer Eagle Analytical Services Disclosures I, Ross Caputo, declare no conflicts of interest, real or apparent, and
More informationOverview of Inspection Issues with Legacy Products. Barbara Breithaupt Consumer Safety Officer
Overview of Inspection Issues with Legacy Products Barbara Breithaupt Consumer Safety Officer 1 Overview of the presentation The role of the Quality Unit will be discussed in the context of the inspection
More informationDISINFECTION QUALIFI CATION TESTING CONSIDERATIONS FOR THE ASEPTIC AND CLEANROOM MANUFACTURING ENVIRONMENT
DISINFECTION QUALIFI CATION TESTING CONSIDERATIONS FOR THE ASEPTIC AND CLEANROOM MANUFACTURING ENVIRONMENT by Dave Rottjakob, M.T. (ASCP) December, 2013 INTRODUCTION Obtaining the highest confidence that
More informationISO INTERNATIONAL STANDARD. Cleanrooms and associated controlled environments Biocontamination control Part 1: General principles and methods
INTERNATIONAL STANDARD ISO 14698-1 First edition 2003-09-01 Cleanrooms and associated controlled environments Biocontamination control Part 1: General principles and methods Salles propres et environnements
More informationRapid Microbiological. PDA: A Global. Methods. Association. Gilberto Dalmaso Aseptic Processes Development Manager
Rapid Microbiological PDA: A Global Methods Association Gilberto Dalmaso Aseptic Processes Development Manager ARMM Presentation Outline A Rapid History of Microbiology The Fundamentals of Traditional
More informationThe ABCs and Challenges of GMP The American Experience
The ABCs and Challenges of GMP The American Experience The Canadian Association of Nuclear Medicine Toronto, Ontario April 22, 2017 Reiko Oyama, R.Ph., B.C.N.P. Washington University School of Medicine
More informationSupplementary Training Modules on Good Manufacturing Practice. Validation. WHO Technical Report Series, No. 937, Annex 4.
Supplementary Training Modules on Good Manufacturing Practice Validation WHO Technical Report Series, No. 937, 2006. Annex 4. Validation Slide 1 of 48 August 2006 Validation! Part 1. General overview on
More informationGetting it Right Microbial Quality Risk Management
Programme Linda Musker Quality Control North West Mark Oldcorne All Wales Pharmaceutical Quality Assurance Getting it Right Microbial Quality Risk Management Strategic Background (MAO) The Problem (LM)
More informationStudy disproves misconception about contamination of sterile IPA bottles.
1 of 6 4/27/2009 11:06 PM Is Your IPA Bottle Doing More Harm Than Good? Lara Soltis, Wendy Hollands, and Allen Spivey July 2006 Study disproves misconception about contamination of sterile IPA bottles.
More informationRapid/Automated Environmental Monitoring on the Manufacturing Floor. Amy McDaniel, Ph.D. IFPAC Arlington, VA January 2014
Rapid/Automated Environmental Monitoring on the Manufacturing Floor Amy McDaniel, Ph.D. IFPAC Arlington, VA January 2014 Outline Introduction to Pfizer Biotech, Sanford Introduction to Rapid Microbial
More informationValidation Needs for Sterilization by Aseptic Filtration
Validation Needs for Sterilization by Aseptic Filtration DCVMN Workshop, Hyderabad, 4-8 April 2016 Ramesh Raju Associate Director - Provantage Validation Services Overview Key Regulatory and Industry guidelines
More informationMicrobiology Research Associates
2017 Microbiology Research Associates List of Services www.mra-bact.com 33 Nagog Park Acton, MA 01720 978.263.2624 Page 1 of 11 Microbiology Tests Pharma/Biotech/Medical Devices Time From Sample Receipt
More informationMICROBIOLOGY AND NEW TECHNOLOGY HOW TECHNOLOGY CAN IMPACT ON MICROBIOLOGICAL CONTROL
MICROBIOLOGY AND NEW TECHNOLOGY HOW TECHNOLOGY CAN IMPACT ON MICROBIOLOGICAL CONTROL DISCUSSION AREAS HOW MICROBIOLOGY NEEDS TO CHANGE TO MEET FUTURE DEMANDS AND PRODUCTION SYSTEMS MICROBIOLOGY AND PAT
More informationPhysical and Biological Efficiency Testing of ImpactAir Microbiological Air Sampler Using Techniques Described in ISO
Physical and Biological Efficiency Testing of ImpactAir Microbiological Air Sampler Using Techniques Described in ISO14698-1 The work presented herein was performed by the Biosafety Investigation Unit
More informationWARNING LETTER CMS #
Office of Medical Device and Radiological Health Operations (OMDRHO) Division 2 Central 555 Winderley Pl # 200 Maitland, FL 32751 Telephone: (407) 475-4700 UNITED PARCEL SERVICE w/delivery CONFIRMATION
More informationCompounding Aseptic Isolators (CAI) James T Wagner
Compounding Aseptic Isolators (CAI) James T Wagner jimwagner@cenvironment.com Disclaimer "Although I am a member of the USP Sterile Compounding Expert Committee, I am speaking today in my individual capacity
More informationTesto Expert Knowledge. The GxP Dictionary 1st edition. Definitions relating to GxP and Quality Assurance
Testo Expert Knowledge The GxP Dictionary 1st edition Definitions relating to GxP and Quality Assurance Note: Some of the information contained in this GxP Dictionary does not apply equally to all countries.
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Seite 1 von 10 Inspections, Compliance, Enforcement, and Criminal Investigations Dabur Oncology PLC hhsbluebird Department of Health and Human Services Warning Letter Public Health Service Food and Drug
More informationWhen Quality Matters. Microbial Air Samplers: Selection Criteria in Biopharma Manufacturing. Celebrating Over 50 Years In Business!
When Quality Matters Celebrating Over 50 Years In Business! Microbial Air Samplers: Selection Criteria in Biopharma Manufacturing Rev. 1.0 (Jan 2016) 1 Doc No.: TN-160104-1 Printed: January 4, 2016 Copyright
More informationPHCT 401 Aseptic Processes & Techniques
PHCT 401 Aseptic Processes & Techniques Principles of Aseptic Techniques Aseptic Processing Sterility Testing Laminar flow air cleaning Quality Control Tests Personnel Principles of Aseptic Techniques
More informationfor IND and RDRC Regulated PET Compounding
Overview of USP Chapter for IND and RDRC Regulated PET Compounding Distributed Manufacturing of PET Radiopharmaceuticals for Multi-Center Clinical Trials SNM, Annual Meeting Toronto, Ontario, Canada
More informationQualification of an Environmental Monitoring Program
[ Scott Sutton Qualification of an Environmental Monitoring Program Scott Sutton Microbiology Topics discusses various topics in microbiology of practical use in validation compliance. We intend this column
More informationValidation Guide USTR 2114 (2) Validation Guide for Pall Emflon PFR Filter Cartridges
Validation Guide USTR 2114 (2) Validation Guide for Pall Emflon PFR Filter Cartridges CONTENTS Part I. Overview 4 1. Introduction 4 2. Summary of Conclusions 4 Part II. Studies on Removal Efficiency 6
More informationContents. Contents (13) 1 Production (23)
1 Production (23) 1.A Sanitation (27) 1.A.1 Organisational prerequisites (27) 1.A.2 Sources of contamination (28) 1.A.3 Responsibilities and implementation (29) 1.B Personnel hygiene (31) 1.B.1 Clothing
More informationcgmp/iso CLIA Experience Unsurpassed Quality
Cert. No. 2254.01 cgmp/iso-17025-2005 CLIA Experience Unsurpassed Quality Polyphasic Microbial Identification & DNA Fingerprinting Microbial Contamination Tracking & Trending Microbial Identification
More informationEnvironmental Monitoring: A New Look at an Old Topic
Environmental Monitoring: A New Look at an Old Topic Jeanne Moldenhauer Excellent Pharma Consulting (c) Jeanne Moldenhauer 2008 1 Regulatory Interest EM has been a topic of increased interest by regulators
More informationAllergy Laboratories, Inc. 10/4/13
Allergy Laboratories, Inc. 10/4/13 SEP 04, 2013 Department of Health and Human Services Public Health Service Food and Drug Administration Office of Regulatory Affairs 12420 Parklawn Drive ELEM-2152 Rockville,
More informationFZ LABORATORY SERVICES
FZ LABORATORY SERVICES For those working in biological product manufacturing/aseptic process filling: you can greatly benefit from support by Franz Ziel GmbH (FZ) with many years experience in scientific
More informationcompounding area based on environmental sampling and cleaning product type. Antiseptics and determine the appropriate use of each.
The pharmacist will be able to: 1. Determine a best practice for cleaning their compounding area based on environmental sampling and cleaning product type. 2. Discuss the difference between Disinfectants
More informationValidation Study on How to Avoid Microbial Contamination during Pharmaceutical Production
Biocontrol Science, 2015, Vol. 20, No.1, 1 10 Review Validation Study on How to Avoid Microbial Contamination during Pharmaceutical Production HIDEHARU SHINTANI 1-13-27, Kasuga, Bunkyo, Tokyo 112-0003,
More informationIsolators v. RABS: Facility Design Considerations for a Fill-Finish Finish Suite
APV 2008 Basle Conference Basle, Switzerland: May 28 & 29 2008 Isolators v. RABS: Facility Design Considerations for a Fill-Finish Finish Suite John R. Chester Principal Engineer Global Pharmaceutical
More informationAseptic Processing Practices and Process Validation of Aseptic Operators
Aseptic Processing Practices and Process Validation of Aseptic Operators CBE Pty Ltd This training program is copyright to CBE Pty Ltd and may not be modified, reproduced, sold, loaned, hired or traded
More informationANALYTICAL REPORT: Comparison of the Microbial Recovery Efficacy of QI Medical EnviroTest Paddles versus a Conventional Contact Plate
FOCUS Scientific Services LLC ANALYTICAL REPORT: Comparison of the Microbial Recovery Efficacy of QI Medical EnviroTest Paddles versus a Conventional Contact Plate REPORT: FS-QI-GM-003 Study Manager: Anthony
More informationWebinar Expert Module 3: GMP Inspections Dupont
Webinar Expert Module 3: GMP Inspections Dupont 26 January & 9 February 2018 GOP-Innovations your Partner for Practical Training and e-learning Milenko Pavičić Pharmaceutical microbiologist, trainer, coach
More informationISPE Nordic, Denmark Yves Scholler SKAN AG
Risk of contamination through pinholes in gloves and how to prove the integrity ISPE Nordic, Denmark Yves Scholler SKAN AG 07.10.2015 1 Agenda 1 Regulatory Requirements 2 Overview of Different Testing
More informationEU GMP ANNEX 1 DRAFT CLARIFICATION AND IMPACT
1 EU GMP ANNEX 1 DRAFT CLARIFICATION AND IMPACT UNDERSTAND THE PROGRESSION OF REGULATORY THINKING AND HOW TO SUCCESSFULLY IMPLEMENT THE PROPOSED DOCUMENTED CONTAMINATION CONTROL STRATEGY SAN FRANCISCO,
More informationYour partner in the pharmaceutical industry
English Micronisation- and milling service Micronised by GfM Your API Particle size (µm) Your partner in the pharmaceutical industry The... always that little bit finer. We are a family business in the
More informationResidue removal in Cleanroom Environments
Residue removal in Cleanroom Environments PDA Midwest Indianapolis Event 06 Oct 2016 Contamination Control Solutions 1/ BIO Beth Kroeger Technical Service Manager STERIS Life Sciences 4 years 24 years
More informationBiological contamination events in isolators: What lessons can be learned?
WHITE PAPER SCIENCE DRIVEN BIO-DECONTAMINATION LS001-MKT-008 Rev 1US Biological contamination events in isolators: What lessons can be learned? James Drinkwater, Bioquell UK Process & Compliance Director.
More informationCase study Microbiological excursion during a phase I PQ of a WFI system. Walid El Azab Technical Service Manager STERIS Life Science
Case study Microbiological excursion during a phase I PQ of a WFI system Walid El Azab Technical Service Manager STERIS Life Science Agenda Agenda Case study Microbiological excursion Description of the
More informationIndustry Case Study: A Microbial Investigation of Contamination by Burkholderia multivorans. Jim Klein and Geert Verdonk Merck & Co., Inc.
Industry Case Study: A Microbial Investigation of Contamination by Burkholderia multivorans Jim Klein and Geert Verdonk Merck & Co., Inc. Messages The role of microbiological analysis The role of subject
More informationUSP <797> and Environmental Sampling
USP and Environmental Sampling Participants will be in listen only mode. 9 a.m. (PT) Download the PDF: https://www.emlab.com/m/media/usp797-webinar.pdf Presented by: Michael Berg, Ph.D. Continuing
More informationStudy Summary. Results: All tested media-filled vials were negative for growth of any microorganisms.
A 7 Days Microbial Ingress Test of Single Use Vials Utilizing the EQUASHIELD Closed System Drug Transfer Device Study by Nelson Laboratories (Salt Lake City, UT) 2013, updated in 2014* Study Summary Abstract:
More informationPHARMACY IV ADMIXTURE. Pharmacy 483 January 17, 2006 Kim Donnelly Affiliate Associate Professor
PHARMACY IV ADMIXTURE Pharmacy 483 January 17, 2006 Kim Donnelly Affiliate Associate Professor Pharmacist is responsible for ensuring that compounded sterile preparations are properly prepared, labeled,
More informationAnnex 1 to the Good manufacturing practices guide Manufacture of sterile drugs GUI-0119
Annex 1 to the Good manufacturing practices guide Manufacture of sterile drugs GUI-0119 February 28, 2018 Manufacture of sterile drugs (GUI-0119) Author: Health Canada Date issued: February 28, 2018 Implementation
More informationAseptic Processing Current Issues & Trends
Aseptic Processing Current Issues & Trends 1 Introduction Richard M. Johnson Member, PDA for 20+ years President & CEO since 2009 Ladies and Gentlemen, I am happy to be here with you. Senhoras e Senhores,
More informationSterilizing and Bioburden Filter Risk Assessment in Vaccine Processes as part of QRM
Sterilizing and Bioburden Filter Risk Assessment in Vaccine Processes as part of QRM DCVMN Workshop, Hyderabad, 4-8 April 2016 G. Somasundaram Associate Director - Technology Management Overview Key Regulatory
More informationMicrobial Identification for the Environmental Monitoring Arena Using MALDI-TOF
Microbial Identification for the Environmental Monitoring Arena Using MALDI-TOF Anne M. Russell, Ph.D. Senior Staff Scientist EMD anne.russell@crl.com Presentation Overview 1. Accugenix - History and Market
More information